CN113683518A - Aromatic amine derivative organic electroluminescent material and device thereof - Google Patents

Aromatic amine derivative organic electroluminescent material and device thereof Download PDF

Info

Publication number
CN113683518A
CN113683518A CN202010418571.2A CN202010418571A CN113683518A CN 113683518 A CN113683518 A CN 113683518A CN 202010418571 A CN202010418571 A CN 202010418571A CN 113683518 A CN113683518 A CN 113683518A
Authority
CN
China
Prior art keywords
substituted
carbon atoms
unsubstituted
groups
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010418571.2A
Other languages
Chinese (zh)
Inventor
田学超
毕欣
张少博
赵春亮
邝志远
夏传军
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing Summer Sprout Technology Co Ltd
Original Assignee
Beijing Summer Sprout Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Summer Sprout Technology Co Ltd filed Critical Beijing Summer Sprout Technology Co Ltd
Priority to CN202010418571.2A priority Critical patent/CN113683518A/en
Publication of CN113683518A publication Critical patent/CN113683518A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/43Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C211/57Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings being part of condensed ring systems of the carbon skeleton
    • C07C211/61Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings being part of condensed ring systems of the carbon skeleton with at least one of the condensed ring systems formed by three or more rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/72Benzo[c]thiophenes; Hydrogenated benzo[c]thiophenes
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/11OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
    • H10K50/12OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers comprising dopants
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/615Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/615Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
    • H10K85/622Polycyclic condensed aromatic hydrocarbons, e.g. anthracene containing four rings, e.g. pyrene
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/631Amine compounds having at least two aryl rest on at least one amine-nitrogen atom, e.g. triphenylamine
    • H10K85/633Amine compounds having at least two aryl rest on at least one amine-nitrogen atom, e.g. triphenylamine comprising polycyclic condensed aromatic hydrocarbons as substituents on the nitrogen atom
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/631Amine compounds having at least two aryl rest on at least one amine-nitrogen atom, e.g. triphenylamine
    • H10K85/636Amine compounds having at least two aryl rest on at least one amine-nitrogen atom, e.g. triphenylamine comprising heteroaromatic hydrocarbons as substituents on the nitrogen atom
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6572Polycyclic condensed heteroaromatic hydrocarbons comprising only nitrogen in the heteroaromatic polycondensed ring system, e.g. phenanthroline or carbazole
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6574Polycyclic condensed heteroaromatic hydrocarbons comprising only oxygen in the heteroaromatic polycondensed ring system, e.g. cumarine dyes
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6576Polycyclic condensed heteroaromatic hydrocarbons comprising only sulfur in the heteroaromatic polycondensed ring system, e.g. benzothiophene
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05Isotopically modified compounds, e.g. labelled
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/12One of the condensed rings being a six-membered aromatic ring the other ring being at least seven-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/04Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/08Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing three- or four-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/04Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/40Ortho- or ortho- and peri-condensed systems containing four condensed rings
    • C07C2603/42Ortho- or ortho- and peri-condensed systems containing four condensed rings containing only six-membered rings
    • C07C2603/50Pyrenes; Hydrogenated pyrenes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/56Ring systems containing bridged rings
    • C07C2603/58Ring systems containing bridged rings containing three rings
    • C07C2603/60Ring systems containing bridged rings containing three rings containing at least one ring with less than six members
    • C07C2603/66Ring systems containing bridged rings containing three rings containing at least one ring with less than six members containing five-membered rings
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1003Carbocyclic compounds
    • C09K2211/1007Non-condensed systems
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1003Carbocyclic compounds
    • C09K2211/1011Condensed systems
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1003Carbocyclic compounds
    • C09K2211/1014Carbocyclic compounds bridged by heteroatoms, e.g. N, P, Si or B
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1029Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1088Heterocyclic compounds characterised by ligands containing oxygen as the only heteroatom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1092Heterocyclic compounds characterised by ligands containing sulfur as the only heteroatom

Abstract

Disclosed are an aromatic amine derivative organic electroluminescent material and a device thereof. The compound is an aromatic amine substituted pyrene compound, wherein one aryl group of arylamine in the compound has a substituted six-membered (hetero) aromatic ring and saturated ring structure, and the other aryl group is a substituted (hetero) aryl group. The compound can be used as a light-emitting material in an organic electroluminescent device. These novel compounds can provide better device performance such as narrower half-peak width and higher external quantum efficiency. An electroluminescent device and compound formulation are also disclosed.

Description

Aromatic amine derivative organic electroluminescent material and device thereof
Technical Field
The present invention relates to compounds for use in organic electronic devices, such as organic electroluminescent devices. And more particularly, to a pyrene compound substituted with an aromatic amine and an organic electroluminescent device and a compound formulation including the same.
Background
Organic electronic devices include, but are not limited to, the following classes: organic Light Emitting Diodes (OLEDs), organic field effect transistors (O-FETs), Organic Light Emitting Transistors (OLETs), Organic Photovoltaics (OPVs), dye-sensitized solar cells (DSSCs), organic optical detectors, organic photoreceptors, organic field effect devices (OFQDs), light emitting electrochemical cells (LECs), organic laser diodes, and organic plasma light emitting devices.
In 1987, Tang and Van Slyke of Islamic Kodak reported a two-layer organic electroluminescent device comprising an arylamine hole transport layer and a tris-8-hydroxyquinoline-aluminum layer as an electron transport layer and a light-emitting layer (Applied Physics Letters, 1987,51(12): 913-915). Upon biasing the device, green light is emitted from the device. The invention lays a foundation for the development of modern Organic Light Emitting Diodes (OLEDs). The most advanced OLEDs may comprise multiple layers, such as charge injection and transport layers, charge and exciton blocking layers, and one or more light emitting layers between the cathode and anode. Since OLEDs are a self-emissive solid state device, it offers great potential for display and lighting applications. Furthermore, the inherent properties of organic materials, such as their flexibility, may make them well suited for particular applications, such as in the fabrication of flexible substrates.
OLEDs can be classified into three different types according to their light emitting mechanisms. The OLEDs invented by Tang and van Slyke are fluorescent OLEDs. It uses only singlet luminescence. The triplet states generated in the device are wasted through the non-radiative decay channel. Therefore, the Internal Quantum Efficiency (IQE) of fluorescent OLEDs is only 25%. This limitation hinders the commercialization of OLEDs. In 1997, Forrest and Thompson reported phosphorescent OLEDs, which use triplet emission from complex-containing heavy metals as emitters. Thus, singlet and triplet states can be harvested, achieving 100% IQE. Due to its high efficiency, the discovery and development of phosphorescent OLEDs directly contributes to the commercialization of active matrix OLEDs (amoleds). Recently, Adachi has achieved high efficiency through Thermally Activated Delayed Fluorescence (TADF) of organic compounds. These emitters have a small singlet-triplet gap, making it possible for excitons to return from the triplet state to the singlet state. In TADF devices, triplet excitons are able to generate singlet excitons through reverse intersystem crossing, resulting in high IQE.
The light emitting color of the OLED can be realized by the structural design of the light emitting material. An OLED may comprise one light emitting layer or a plurality of light emitting layers to achieve a desired spectrum. Green, yellow and red OLED phosphorescent materials have been successfully commercialized. The existing phosphorescent blue OLED has the problems of short service life, difficulty in reaching deep blue, blue unsaturation, high working voltage and the like. The fluorescent blue OLED has a longer lifetime than the phosphorescent blue OLED, but has a low efficiency, and thus it is highly desirable to improve the efficiency and other properties of the fluorescent blue electroluminescent device.
WO2010013676A1 discloses diaminopyrene derivatives of the general formula
Figure BDA0002495324990000011
Wherein, discloses an aminopyrene derivative partially substituted by benzocyclohydrocarbon, and the specific structure is
Figure BDA0002495324990000012
Figure BDA0002495324990000021
And the like. However, the patent application does not examine the influence of the introduction of benzocyclohydrocarbon on the device performance, and does not recognize the advantages of the introduction of benzocyclohydrocarbon or the connection of other groups on the benzene ring of benzocyclohydrocarbon, and does not recognize the different effects of the position change of the substituent of the benzoalicyclic ring.
CN109678729A discloses a pyrene compound containing a benzocyclohexane structure, which has a general formula shown in the specification
Figure BDA0002495324990000022
Wherein Ar is2Is selected from
Figure BDA0002495324990000023
The concrete structure is that
Figure BDA0002495324990000024
And the like. However, only the compounds of benzocyclohexanes with only a few structures are disclosed in the patent application, the influence of the introduction of the benzocyclohexanes on the device performance is not examined, and the device effect obtained by further substitution on the benzene ring of the benzocyclohexanes which is a non-six-membered ring is not disclosed and taught.
CN107556239A discloses a pyrene compound containing an acridine structure, which has a general formula shown in the specification
Figure BDA0002495324990000025
Wherein Ar is1And Ar2Can be heterocyclic radical, and has specific structure
Figure BDA0002495324990000031
However, the patent application mainly aims at a series of pyrene compounds with acridine substituted aromatic amine, does not pay attention to improvement of device performance caused by benzo-heterocyclic hydrocarbon, and does not disclose and teach that better device effect can be achieved by connecting other groups to the benzene ring of the benzo-heterocyclic hydrocarbon.
These documents disclose fluorescent light-emitting materials having an aromatic amine structure with pyrene as a core. However, the fluorescent light-emitting material still needs to be developed further to obtain higher device performance.
Disclosure of Invention
The present invention aims to solve at least part of the above problems by providing a series of novel pyrene-based compounds having a substituted six-membered (hetero) aromatic ring and an aromatic amine structure of a saturated ring and a substituted (hetero) aryl group.
According to one embodiment of the present invention, a compound having the structure of formula 1 is disclosed:
Figure BDA0002495324990000032
wherein, in the formula 1,
substituent R1-R10At least one of which has the structure of formula 2:
Figure BDA0002495324990000033
and the substituent Rl-Rl0The remainder of which are, on each occurrence, identically or differently selected from the group consisting of hydrogen, deuterium, halogen, substituted or unsubstituted alkyl having from 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl having from 3 to 20 ring carbon atoms, substituted or unsubstituted heteroalkyl having from 1 to 20 carbon atoms, substituted or unsubstituted aralkyl having from 7 to 30 carbon atoms, substituted or unsubstituted alkoxy having from 1 to 20 carbon atoms, substituted or unsubstituted aryloxy having from 6 to 30 carbon atoms, substituted or unsubstituted alkenyl having from 2 to 20 carbon atoms, substituted or unsubstituted aryl having from 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl having from 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl having from 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl groups having 6 to 20 carbon atoms, substituted or unsubstituted amino groups having 0 to 20 carbon atoms, acyl groups, carbonyl groups, carboxylic acid groups, ester groups, cyano groups, isocyano groups, mercapto groups, sulfinyl groups, sulfonyl groups, phosphino groups, and combinations thereof;
wherein, in the formula 2,
l is selected, identically or differently on each occurrence, from a single bond, a substituted or unsubstituted arylene group having 6 to 60 carbon atoms, a substituted or unsubstituted heteroarylene group having 3 to 60 carbon atoms, or a combination thereof;
X1-X5selected, identically or differently at each occurrence, from C, CRx1,CRx2Or N; and X1-X5At least two of them are adjacent to each other and are connected with the group of formula 2, X1-X5At least one of which is CRx2
Y1-Y5Selected from CR, identically or differently at each occurrencey1,CRy2Or N; and Y is1-Y5At least one of which is CRy2
Z is selected, identically or differently on each occurrence, from C (R)z)2,NRzO, S or Se;
Rx1and Ry1Each occurrence, the same or different, is selected from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted heteroalkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted aralkyl groups having 7 to 30 carbon atoms, substituted or unsubstituted alkoxy groups having 1 to 20 carbon atoms, substituted or unsubstituted aryloxy groups having 6 to 30 carbon atoms, substituted or unsubstituted alkenyl groups having 2 to 20 carbon atoms, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl groups having 6 to 20 carbon atoms, substituted or unsubstituted amino, acyl, carbonyl, carboxylic acid group, ester group, cyano, isocyano, mercapto, sulfinyl, sulfonyl, phosphino, and combinations thereof, having from 0 to 20 carbon atoms;
Rx2and Ry2Each occurrence, the same or different, is selected from the group consisting of: deuterium, halogen, substituted or unsubstituted alkyl having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl having 3 to 20 ring carbon atoms, substituted or unsubstituted heteroalkyl having 1 to 20 carbon atoms, substituted or unsubstituted aralkyl having 7 to 30 carbon atoms, substituted or unsubstituted alkoxy having 1 to 20 carbon atoms, substituted or unsubstituted aryloxy having 6 to 30 carbon atoms, substituted or unsubstituted alkenyl having 2 to 20 carbon atoms, substituted or unsubstituted aryl having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl having 3 to 20 carbon atomsSubstituted or unsubstituted arylsilyl groups having 6 to 20 carbon atoms, substituted or unsubstituted amino groups having 0 to 20 carbon atoms, acyl groups, carbonyl groups, carboxylic acid groups, ester groups, cyano groups, isocyano groups, mercapto groups, sulfinyl groups, sulfonyl groups, phosphino groups, and combinations thereof;
represents the position of the substituent with the structure of formula 2 connected with formula 1;
n is 0, 1,2, 3,4 or 5;
Rzeach occurrence, the same or different, is selected from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted heteroalkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted aralkyl groups having 7 to 30 carbon atoms, substituted or unsubstituted alkoxy groups having 1 to 20 carbon atoms, substituted or unsubstituted aryloxy groups having 6 to 30 carbon atoms, substituted or unsubstituted alkenyl groups having 2 to 20 carbon atoms, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl groups having 6 to 20 carbon atoms, and combinations thereof;
adjacent substituents Rx1,Rx2,Ry1,Ry2Can optionally be linked to form a ring.
According to another embodiment of the present invention, there is also disclosed an electroluminescent device comprising the compound having the structure of formula 1. The specific structures of the compounds are described in the preceding examples.
According to another embodiment of the present invention, there is also disclosed a compound formulation comprising the compound having the structure of formula 1. Specific structures of the compounds are described in the preceding examples.
The invention provides a series of novel pyrene compounds with substituted hexatomic (hetero) aromatic ring, saturated ring and substituted (hetero) aryl aromatic amine structures, which can be used as luminescent materials in organic electroluminescent devices. These novel compounds can provide better device performance such as narrower half-peak width and higher external quantum efficiency.
Drawings
FIG. 1 is a schematic representation of an organic light emitting device that can contain the compounds and compound formulations disclosed herein.
Fig. 2 is a schematic view of another organic light emitting device that can contain compounds and compound formulations disclosed herein.
Detailed Description
OLEDs can be fabricated on a variety of substrates, such as glass, plastic, and metal. Fig. 1 schematically, but without limitation, illustrates an organic light emitting device 100. The figures are not necessarily to scale, and some of the layer structures in the figures may be omitted as desired. The device 100 may include a substrate 101, an anode 110, a hole injection layer 120, a hole transport layer 130, an electron blocking layer 140, an emissive layer 150, a hole blocking layer 160, an electron transport layer 170, an electron injection layer 180, and a cathode 190. The device 100 may be fabricated by sequentially depositing the described layers. The nature and function of the layers, as well as exemplary materials, are described in more detail in U.S. patent US7,279,704B2, columns 6-10, which is incorporated herein by reference in its entirety.
There are more instances of each of these layers. For example, a flexible and transparent substrate-anode combination is disclosed in U.S. Pat. No. 5,844,363, which is incorporated by reference in its entirety. An example of a p-doped hole transport layer is doped with F at a molar ratio of 50:14TCNQ m-MTDATA as disclosed in U.S. patent application publication No. 2003/0230980, which is incorporated by reference in its entirety. Examples of host materials are disclosed in U.S. patent No. 6,303,238 to Thompson et al, which is incorporated by reference in its entirety. An example of an n-doped electron transport layer is BPhen doped with Li at a molar ratio of 1:1, as disclosed in U.S. patent application publication No. 2003/0230980, which is incorporated by reference in its entirety. U.S. Pat. Nos. 5,703,436 and 5,707,745, which are incorporated by reference in their entirety, disclose examples of cathodes including composite cathodes having a thin layer of a metal such as Mg: Ag and an overlying layer of transparent, conductive, sputter-deposited ITO. The method being incorporated by reference in its entiretyThe principle and use of barrier layers is described in more detail in U.S. patent No. 6,097,147 and U.S. patent application publication No. 2003/0230980, both of which are incorporated by reference. Examples of injection layers are provided in U.S. patent application publication No. 2004/0174116, which is incorporated by reference in its entirety. A description of the protective layer may be found in U.S. patent application publication No. 2004/0174116, which is incorporated by reference in its entirety.
The above-described hierarchical structure is provided via non-limiting embodiments. The function of the OLED may be achieved by combining the various layers described above, or some layers may be omitted entirely. It may also include other layers not explicitly described. Within each layer, a single material or a mixture of materials may be used to achieve optimal performance. Any functional layer may comprise several sub-layers. For example, the light emitting layer may have two layers of different light emitting materials to achieve a desired light emission spectrum.
In one embodiment, an OLED may be described as having an "organic layer" disposed between a cathode and an anode. The organic layer may include one or more layers.
The OLED also requires an encapsulation layer, as shown in fig. 2, which is an exemplary, non-limiting illustration of an organic light emitting device 200, which differs from fig. 1 in that an encapsulation layer 102 may also be included over the cathode 190 to protect against harmful substances from the environment, such as moisture and oxygen. Any material capable of providing an encapsulation function may be used as the encapsulation layer, such as glass or a hybrid organic-inorganic layer. The encapsulation layer should be placed directly or indirectly outside the OLED device. Multilayer film encapsulation is described in U.S. patent US7,968,146B2, the entire contents of which are incorporated herein by reference.
Devices manufactured according to embodiments of the present invention may be incorporated into various consumer products having one or more electronic component modules (or units) of the device. Some examples of such consumer products include flat panel displays, monitors, medical monitors, televisions, billboards, lights for indoor or outdoor lighting and/or signaling, head-up displays, fully or partially transparent displays, flexible displays, smart phones, tablet computers, tablet handsets, wearable devices, smart watches, laptop computers, digital cameras, camcorders, viewfinders, micro-displays, 3-D displays, vehicle displays, and tail lights.
The materials and structures described herein may also be used in other organic electronic devices as previously listed.
As used herein, "top" means furthest from the substrate, and "bottom" means closest to the substrate. Where a first layer is described as being "disposed on" a second layer, the first layer is disposed farther from the substrate. Other layers may be present between the first and second layers, unless it is specified that the first layer is "in contact with" the second layer. For example, a cathode can be described as being "disposed on" an anode even though various organic layers are present between the cathode and the anode.
As used herein, "solution processable" means capable of being dissolved, dispersed or transported in and/or deposited from a liquid medium in the form of a solution or suspension.
A ligand may be referred to as "photoactive" when it is believed that the ligand directly contributes to the photoactive properties of the emissive material. A ligand may be referred to as "ancillary" when it is believed that the ligand does not contribute to the photoactive properties of the emissive material, but the ancillary ligand may alter the properties of the photoactive ligand.
It is believed that the Internal Quantum Efficiency (IQE) of fluorescent OLEDs can be limited by delaying fluorescence beyond 25% spin statistics. Delayed fluorescence can generally be divided into two types, i.e., P-type delayed fluorescence and E-type delayed fluorescence. P-type delayed fluorescence results from triplet-triplet annihilation (TTA).
On the other hand, E-type delayed fluorescence does not depend on collision of two triplet states, but on conversion between triplet and singlet excited states. Compounds capable of producing E-type delayed fluorescence need to have a very small mono-triplet gap in order to switch between energy states. Thermal energy can activate a transition from a triplet state back to a singlet state. This type of delayed fluorescence is also known as Thermally Activated Delayed Fluorescence (TADF). A significant feature of TADF is that the retardation component increases with increasing temperature. If the reverse intersystem crossing (IRISC) rate is fast enough to minimize non-radiative decay from the triplet state, then the fraction of the backfill singlet excited state may reach 75%. The total singlet fraction may be 100%, far exceeding 25% of the spin statistics of the electrogenerated excitons.
The delayed fluorescence characteristic of type E can be found in excited complex systems or in single compounds. Without being bound by theory, it is believed that E-type delayed fluorescence requires the light emitting material to have a small mono-triplet energy gap (Δ Ε)S-T). Organic non-metal containing donor-acceptor emissive materials may be able to achieve this. The emission of these materials is generally characterized as donor-acceptor Charge Transfer (CT) type emission. Spatial separation of HOMO from LUMO in these donor-acceptor type compounds generally results in small Δ ES-T. These states may include CT states. Generally, donor-acceptor light emitting materials are constructed by linking an electron donor moiety (e.g., an amino or carbazole derivative) to an electron acceptor moiety (e.g., a six-membered, N-containing, aromatic ring).
Definitions for substituent terms
Halogen or halide-as used herein, includes fluorine, chlorine, bromine and iodine.
Alkyl-comprises both straight and branched chain alkyl groups. Examples of alkyl groups include methyl, ethyl, propyl, isopropyl, n-butyl, sec-butyl, isobutyl, tert-butyl, n-pentyl, n-hexyl, n-heptyl, n-octyl, n-nonyl, n-decyl, n-undecyl, n-dodecyl, n-tridecyl, n-tetradecyl, n-pentadecyl, n-hexadecyl, n-heptadecyl, n-octadecyl, neopentyl, 1-methylpentyl, 2-methylpentyl, 1-pentylhexyl, 1-butylpentyl, 1-heptyloctyl, 3-methylpentyl. In addition, the alkyl group may be optionally substituted. The carbons in the alkyl chain may be substituted with other heteroatoms. Among the above, methyl, ethyl, propyl, isopropyl, n-butyl, sec-butyl, isobutyl, tert-butyl, n-pentyl and neopentyl are preferable.
Cycloalkyl-as used herein, comprises a cyclic alkyl group. Preferred cycloalkyl groups are those containing 4 to 10 ring carbon atoms and include cyclobutyl, cyclopentyl, cyclohexyl, 4-methylcyclohexyl, 4, 4-dimethylcyclohexyl, 1-adamantyl, 2-adamantyl, 1-norbornyl, 2-norbornyl and the like. In addition, the cycloalkyl group may be optionally substituted. The carbon in the ring may be substituted with other heteroatoms.
Alkenyl-as used herein, encompasses both straight and branched chain olefinic groups. Preferred alkenyl groups are those containing 2 to 15 carbon atoms. Examples of the alkenyl group include a vinyl group, an allyl group, a 1-butenyl group, a 2-butenyl group, a 3-butenyl group, a1, 3-butadienyl group, a 1-methylvinyl group, a styryl group, a 2, 2-diphenylvinyl group, a 1-methylallyl group, a1, 1-dimethylallyl group, a 2-methylallyl group, a 1-phenylallyl group, a 3, 3-diphenylallyl group, a1, 2-dimethylallyl group, a 1-phenyl-1-butenyl group and a 3-phenyl-1-butenyl group. In addition, alkenyl groups may be optionally substituted.
Alkynyl-as used herein, straight and branched alkynyl groups are contemplated. Preferred alkynyl groups are those containing 2 to 15 carbon atoms. In addition, alkynyl groups may be optionally substituted.
Aryl or aromatic-as used herein, non-fused and fused systems are contemplated. Preferred aryl groups are those containing from 6 to 60 carbon atoms, more preferably from 6 to 20 carbon atoms, and even more preferably from 6 to 12 carbon atoms. Examples of aryl groups include phenyl, biphenyl, terphenyl, triphenylene, tetraphenylene, naphthalene, anthracene, phenalene, phenanthrene, fluorene, pyrene, chicory, perylene and azulene, preferably phenyl, biphenyl, terphenyl, triphenylene, fluorene and naphthalene. In addition, the aryl group may be optionally substituted. Examples of non-fused aryl groups include phenyl, biphenyl-2-yl, biphenyl-3-yl, biphenyl-4-yl, p-terphenyl-4-yl, p-terphenyl-3-yl, p-triphenyl-2-yl, m-terphenyl-4-yl, m-terphenyl-3-yl, m-terphenyl-2-yl, o-tolyl, m-tolyl, p-tolyl, p- (2-phenylpropyl) phenyl, 4 '-methyldiphenyl, 4' -tert-butyl-p-terphenyl-4-yl, o-cumyl, m-cumyl, p-cumyl, 2, 3-xylyl, 3, 4-xylyl, 2, 5-xylyl, mesityl and m-quaterphenyl.
Heterocyclyl or heterocyclic-as used herein, aromatic and non-aromatic cyclic groups are contemplated. Heteroaryl also refers to heteroaryl. Preferred non-aromatic heterocyclic groups are those containing 3 to 7 ring atoms, which include at least one heteroatom such as nitrogen, oxygen and sulfur. The heterocyclic group may also be an aromatic heterocyclic group having at least one hetero atom selected from a nitrogen atom, an oxygen atom, a sulfur atom and a selenium atom.
Heteroaryl-as used herein, non-fused and fused heteroaromatic groups are contemplated which may contain 1 to 5 heteroatoms. Preferred heteroaryl groups are those containing from 3 to 30 carbon atoms, more preferably from 3 to 20 carbon atoms, more preferably from 3 to 12 carbon atoms. Suitable heteroaryl groups include dibenzothiophene, dibenzofuran, dibenzoselenophene, furan, thiophene, benzofuran, benzothiophene, benzoselenophene, carbazole, indolocarbazole, pyridine indole, pyrrolopyridine, pyrazole, imidazole, triazole, oxazole, thiazole, oxadiazole, bisoxazole, thiadiazole, pyridine, pyridazine, pyrimidine, pyrazine, triazine, oxazine, oxathiazine, oxadiazine, indoline, benzimidazole, indazole, indenozine, benzoxazole, benzisoxazole, benzothiazole, quinoline, isoquinoline, cinnoline, quinazoline, quinoxaline, naphthyridine, phthalazine, pteridine, xanthene, acridine, phenazine, phenothiazine, benzothienopyridine, thienobipyridine, benzothiophenopyridine, cinnolinopyrimidine, selenobenzodipyridine, selenobenzene, preferably dibenzothiophene, dibenzofuran, dibenzoselenophene, carbazole, indolocarbazole, imidazole, pyridine, triazine, benzimidazole, 1, 2-azaborine, 1, 3-azaborine, 1, 4-azaborine, borazole, and aza analogues thereof. In addition, the heteroaryl group may be optionally substituted.
Alkoxy-is represented by-O-alkyl. Examples and preferred examples of the alkyl group are the same as those described above. Examples of the alkoxy group having 1 to 20 carbon atoms, preferably 1 to 6 carbon atoms include methoxy, ethoxy, propoxy, butoxy, pentyloxy and hexyloxy. The alkoxy group having 3 or more carbon atoms may be linear, cyclic or branched.
Aryloxy-is represented by-O-aryl or-O-heteroaryl. Examples and preferred examples of aryl and heteroaryl groups are the same as described above. Examples of the aryloxy group having 6 to 40 carbon atoms include a phenoxy group and a biphenyloxy group.
Aralkyl-as used herein, an alkyl group having an aryl substituent. In addition, the aralkyl group may be optionally substituted. Examples of the aralkyl group include benzyl, 1-phenylethyl, 2-phenylethyl, 1-phenylisopropyl, 2-phenylisopropyl, phenyl tert-butyl, α -naphthylmethyl, 1- α -naphthylethyl, 2- α -naphthylethyl, 1- α -naphthylisopropyl, 2- α -naphthylisopropyl, β -naphthylmethyl, 1- β -naphthylethyl, 2- β -naphthylethyl, 1- β -naphthylisopropyl, 2- β -naphthylisopropyl, p-methylbenzyl, m-methylbenzyl, o-methylbenzyl, p-chlorobenzyl, m-chlorobenzyl, o-chlorobenzyl, p-bromobenzyl, m-bromobenzyl, o-bromobenzyl, p-iodobenzyl, m-iodobenzyl, o-iodobenzyl, p-hydroxybenzyl, m-hydroxybenzyl, o-hydroxybenzyl, p-aminobenzyl, m-aminobenzyl, o-aminobenzyl, p-nitrobenzyl, m-nitrobenzyl, o-nitrobenzyl, p-cyanobenzyl, m-cyanobenzyl, o-cyanobenzyl, 1-2-hydroxy-2-phenylisopropyl and 1-chloro-2-phenylisopropyl. Among the above, benzyl, p-cyanobenzyl, m-cyanobenzyl, o-cyanobenzyl, 1-phenylethyl, 2-phenylethyl, 1-phenylisopropyl and 2-phenylisopropyl are preferable.
The term "aza" in azafluorene, azaspirobifluorene ring, azadibenzofuran, aza-dibenzothiophene, etc., means that one or more C-H groups in the corresponding aromatic moiety are replaced by a nitrogen atom. For example, azatriphenylenes include dibenzo [ f, h ] quinoxalines, dibenzo [ f, h ] quinolines, and other analogs having two or more nitrogens in the ring system. Other nitrogen analogs of the above-described aza derivatives may be readily envisioned by one of ordinary skill in the art, and all such analogs are intended to be encompassed within the terms described herein.
In this disclosure, unless otherwise defined, when any one of the terms in the group consisting of: substituted alkyl, substituted cycloalkyl, substituted heteroalkyl, substituted aralkyl, substituted alkoxy, substituted aryloxy, substituted alkenyl, substituted aryl, substituted heteroaryl, substituted alkylsilyl, substituted arylsilyl, substituted amino, substituted acyl, substituted carbonyl, substituted carboxylic acid, substituted ester, substituted sulfinyl, substituted sulfonyl, substituted phosphino, meaning alkyl, cycloalkyl, heteroalkyl, aralkyl, alkoxy, aryloxy, alkenyl, aryl, heteroaryl, alkylsilyl, arylsilyl, amino, acyl, carbonyl, carboxylic acid, ester, sulfinyl, sulfonyl and phosphino, any of which groups may be substituted with one or more members selected from deuterium, unsubstituted alkyl having 1 to 20 carbon atoms, unsubstituted cycloalkyl having 3 to 20 ring carbon atoms, an unsubstituted heteroalkyl group having from 1 to 20 carbon atoms, an unsubstituted aralkyl group having from 7 to 30 carbon atoms, an unsubstituted alkoxy group having from 1 to 20 carbon atoms, an unsubstituted aryloxy group having from 6 to 30 carbon atoms, an unsubstituted alkenyl group having from 2 to 20 carbon atoms, an unsubstituted aryl group having from 6 to 30 carbon atoms or, preferably, an unsubstituted aryl group having from 6 to 12 carbon atoms, an unsubstituted heteroaryl group having from 3 to 30 carbon atoms or, preferably, an unsubstituted heteroaryl group having from 3 to 12 carbon atoms, an unsubstituted alkylsilyl group having from 3 to 20 carbon atoms, an unsubstituted arylsilyl group having from 6 to 20 carbon atoms, an unsubstituted amino group having from 0 to 20 carbon atoms, an acyl group, a carbonyl group, a carboxylic acid group, ester, cyano, isocyano, mercapto, sulfinyl, sulfonyl, phosphino, and combinations thereof.
It will be understood that when a molecular fragment is described as a substituent or otherwise attached to another moiety, its name may be written depending on whether it is a fragment (e.g., phenyl, phenylene, naphthyl, dibenzofuranyl) or depending on whether it is an entire molecule (e.g., benzene, naphthalene, dibenzofuran). As used herein, these different ways of specifying substituents or linking fragments are considered to be equivalent.
In the compounds mentioned in the present disclosure, a hydrogen atom may be partially or completely replaced by deuterium. Other atoms such as carbon and nitrogen may also be replaced by their other stable isotopes. Substitution of other stable isotopes in the compounds may be preferred because it enhances the efficiency and stability of the device. In the compounds mentioned in the present disclosure, a deuterated substituent, such as deuterated methyl, means that at least one hydrogen atom in said substituent (methyl) is replaced by deuterium.
In the compounds mentioned in the present disclosure, multiple substitution means that a double substitution is included up to the range of the maximum available substitutions. When a substituent in a compound mentioned in the present disclosure represents multiple substitution (including di-substitution, tri-substitution, tetra-substitution, etc.), that is, it means that the substituent may exist at a plurality of available substitution positions on its connecting structure, and the substituent existing at each of the plurality of available substitution positions may be the same structure or different structures.
In the compounds mentioned in the present disclosure, adjacent substituents in the compounds cannot be linked to form a ring unless specifically defined, for example, adjacent substituents can be optionally linked to form a ring. In the compounds mentioned in the present disclosure, adjacent substituents can be optionally linked to form a ring, including both the case where adjacent substituents may be linked to form a ring and the case where adjacent substituents are not linked to form a ring. When adjacent substituents can optionally be joined to form a ring, the ring formed can be monocyclic or polycyclic, as well as alicyclic, heteroalicyclic, aromatic or heteroaromatic rings. In this expression, adjacent substituents may refer to substituents bonded to the same atom, substituents bonded to carbon atoms directly bonded to each other, or substituents bonded to carbon atoms further away. Preferably, adjacent substituents refer to substituents bonded to the same carbon atom as well as substituents bonded to carbon atoms directly bonded to each other.
The expression that two adjacent substituents can optionally be linked to form a ring is also intended to mean that two substituents bonded to the same carbon atom are linked to each other by a chemical bond to form a ring, which can be exemplified by the following formula:
Figure BDA0002495324990000081
the expression that two adjacent substituents can optionally be linked to form a ring is also intended to mean that two substituents bonded to carbon atoms directly bonded to each other are linked to each other by a chemical bond to form a ring, which can be exemplified by the following formula:
Figure BDA0002495324990000082
further, the expression that two adjacent substituents can be optionally connected to form a ring is also intended to be taken to mean that, in the case where one of the two substituents bonded to the carbon atom directly bonded to each other represents hydrogen, the second substituent is bonded at the position to which the hydrogen atom is bonded, thereby forming a ring. This is exemplified by the following equation:
Figure BDA0002495324990000083
according to one embodiment of the present invention, a compound having the structure of formula 1 is disclosed:
Figure BDA0002495324990000091
wherein, in the formula 1,
substituent R1-R10At least one of which has the structure of formula 2:
Figure BDA0002495324990000092
and the substituent R1-R10The remaining of (a) are, identically or differently on each occurrence, selected from the group consisting of: hydrogen, deuterium, halogen, a substituted or unsubstituted alkyl group having 1 to 20 carbon atoms, a substituted or unsubstituted cycloalkyl group having 3 to 20 ring carbon atoms, a substituted or unsubstituted heteroalkyl group having 1 to 20 carbon atoms, a substituted or unsubstituted aralkyl group having 7 to 30 carbon atoms, a substituted or unsubstituted alkoxy group having 1 to 20 carbon atoms, a substituted or unsubstituted aryloxy group having 6 to 30 carbon atoms, a substituted or unsubstituted alkenyl group having 2 to 20 carbon atoms, a substituted or unsubstituted aryl group having 6 to 30 carbon atoms, a substituted or unsubstituted heteroaryl group having 3 to 30 carbon atoms, a substituted or unsubstituted alkylsilyl group having 3 to 20 carbon atoms, a substituted or unsubstituted aryl silicon group having 6 to 20 carbon atoms.An alkyl group, a substituted or unsubstituted amino group having 0-20 carbon atoms, an acyl group, a carbonyl group, a carboxylic acid group, an ester group, a cyano group, an isocyano group, a mercapto group, a sulfinyl group, a sulfonyl group, a phosphino group, and combinations thereof;
wherein, in the formula 2,
l is selected, identically or differently on each occurrence, from a single bond, a substituted or unsubstituted arylene group having 6 to 60 carbon atoms, a substituted or unsubstituted heteroarylene group having 3 to 60 carbon atoms, or a combination thereof;
X1-X5selected, identically or differently at each occurrence, from C, CRx1,CRx2Or N; and X1-X5At least two of them are adjacent to each other and are connected with the group of formula 2, X1-X5At least one of which is CRx2
Y1-Y5Selected from CR, identically or differently at each occurrencey1,CRy2Or N; and Y is1-Y5At least one of which is CRy2
Z is selected, identically or differently on each occurrence, from C (R)z)2,NRzO, S or Se;
Rx1and Ry1Each occurrence, the same or different, is selected from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted heteroalkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted aralkyl groups having 7 to 30 carbon atoms, substituted or unsubstituted alkoxy groups having 1 to 20 carbon atoms, substituted or unsubstituted aryloxy groups having 6 to 30 carbon atoms, substituted or unsubstituted alkenyl groups having 2 to 20 carbon atoms, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl groups having 6 to 20 carbon atoms, substituted or unsubstituted amino, acyl, carbonyl, carboxylic acid, ester, cyano, isocyano, mercapto, sulfinyl, sulfonyl, phosphine having from 0 to 20 carbon atomsA base, and combinations thereof;
Rx2and Ry2Each occurrence, the same or different, is selected from the group consisting of: deuterium, halogen, a substituted or unsubstituted alkyl group having 1 to 20 carbon atoms, a substituted or unsubstituted cycloalkyl group having 3 to 20 ring carbon atoms, a substituted or unsubstituted heteroalkyl group having 1 to 20 carbon atoms, a substituted or unsubstituted aralkyl group having 7 to 30 carbon atoms, a substituted or unsubstituted alkoxy group having 1 to 20 carbon atoms, a substituted or unsubstituted aryloxy group having 6 to 30 carbon atoms, a substituted or unsubstituted alkenyl group having 2 to 20 carbon atoms, a substituted or unsubstituted aryl group having 6 to 30 carbon atoms, a substituted or unsubstituted heteroaryl group having 3 to 30 carbon atoms, a substituted or unsubstituted alkylsilyl group having 3 to 20 carbon atoms, a substituted or unsubstituted arylsilyl group having 6 to 20 carbon atoms, substituted or unsubstituted amino, acyl, carbonyl, carboxylic acid group, ester group, cyano, isocyano, mercapto, sulfinyl, sulfonyl, phosphino, and combinations thereof, having from 0 to 20 carbon atoms;
represents the position of the substituent with the structure of formula 2 connected with formula 1;
n is 0, 1,2, 3,4 or 5;
Rzeach occurrence, the same or different, is selected from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted heteroalkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted aralkyl groups having 7 to 30 carbon atoms, substituted or unsubstituted alkoxy groups having 1 to 20 carbon atoms, substituted or unsubstituted aryloxy groups having 6 to 30 carbon atoms, substituted or unsubstituted alkenyl groups having 2 to 20 carbon atoms, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl groups having 6 to 20 carbon atoms, and combinations thereof;
adjacent substituents Rx1,Rx2,Ry1,Ry2Can optionally be linked to form a ring;
substituent RzCan optionally be linked to form a ring.
In this embodiment, the "adjacent substituents Rx1,Rx2,Ry1,Ry2Optionally joined to form a ring "may comprise any one or more of the following: one is the case where there is a connecting ring between adjacent substituents, e.g. adjacent substituents Rx1And Rx1Adjacent and adjacent substituents Rx1And Rx2Adjacent and adjacent substituents Rx2And Rx2Adjacent and adjacent substituents Ry1And Ry1Adjacent and adjacent substituents Ry1And Ry2The substituents R being adjacent and adjacenty2And Ry2There may be a case where the rings are connected to each other. Alternatively, the adjacent substituents may be not connected to each other to form a ring.
In this example, the "substituent R" iszOptionally joined to form a ring "may comprise any one or more of the following: in one case for the substituent RzIn which there is a connection to form a ring, e.g. when two or more R's are present simultaneouslyzWhen R is equal tozIn which there is a connection to form a ring, e.g. RzThe two are connected to form a ring to form a spiral ring or bridge ring structure. Another case is for the substituent RzMay not be connected to form a ring.
In this example, the substituent R in formula 11To R10Wherein at least one substituent has the structure of formula 2, and R1To R10The remainder of (a) are selected, identically or differently on each occurrence, from the group consisting of the substituents mentioned above. For example, when the substituent R1Having the structure of formula 2, then R1To R10The remainder of (1), namely R2To R10Each occurrence is selected, identically or differently, from the group consisting of the substituents mentioned above. When the substituent R is1And R6Having the structure of formula 2, then R1To R10The remainder of (1), namely R2To R5And R7To R10Each occurrence is selected, identically or differently, from the group consisting of the substituents mentioned above.
According to one embodiment of the present invention, wherein the substituent having formula 2 further has a structure of formula 3 or formula 4:
Figure BDA0002495324990000101
wherein, in formula 3 and formula 4,
in formula 3, X1-X3Selected from CR, identically or differently at each occurrencex1,CRx2Or N; and at least one is CRx2
In formula 4, X1-X2And X5Selected from CR, identically or differently at each occurrencex1,CRx2Or N; and at least one is CRx2
Y1-Y5Selected from CR, identically or differently at each occurrencey1,CRy2Or N; and Y is1-Y5At least one of which is CRy2
L is selected, identically or differently on each occurrence, from a single bond, a substituted or unsubstituted arylene group having 6 to 60 carbon atoms, a substituted or unsubstituted heteroarylene group having 3 to 60 carbon atoms, or a combination thereof;
z is selected, identically or differently on each occurrence, from C (R)z)2,NRzO, S or Se;
n is 0, 1,2, 3,4 or 5;
Rx1and Ry1Each occurrence, the same or different, is selected from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl having 3 to 20 ring carbon atoms, substituted or unsubstituted heteroalkyl having 1 to 20 carbon atoms, substituted or unsubstituted aralkyl having 7 to 30 carbon atoms, substituted or unsubstituted alkoxy having 1 to 20 carbon atoms, substituted or unsubstituted aryloxy having 6 to 30 carbon atoms, substituted or unsubstituted aralkyl having 2 to 20 carbon atomsAn alkenyl group of carbon atoms, a substituted or unsubstituted aryl group having 6 to 30 carbon atoms, a substituted or unsubstituted heteroaryl group having 3 to 30 carbon atoms, a substituted or unsubstituted alkylsilyl group having 3 to 20 carbon atoms, a substituted or unsubstituted arylsilyl group having 6 to 20 carbon atoms, a substituted or unsubstituted amino group having 0 to 20 carbon atoms, an acyl group, a carbonyl group, a carboxylic acid group, an ester group, a cyano group, an isocyano group, a mercapto group, a sulfinyl group, a sulfonyl group, a phosphino group, and combinations thereof;
Rx2and Ry2Each occurrence, the same or different, is selected from the group consisting of: deuterium, halogen, a substituted or unsubstituted alkyl group having 1 to 20 carbon atoms, a substituted or unsubstituted cycloalkyl group having 3 to 20 ring carbon atoms, a substituted or unsubstituted heteroalkyl group having 1 to 20 carbon atoms, a substituted or unsubstituted aralkyl group having 7 to 30 carbon atoms, a substituted or unsubstituted alkoxy group having 1 to 20 carbon atoms, a substituted or unsubstituted aryloxy group having 6 to 30 carbon atoms, a substituted or unsubstituted alkenyl group having 2 to 20 carbon atoms, a substituted or unsubstituted aryl group having 6 to 30 carbon atoms, a substituted or unsubstituted heteroaryl group having 3 to 30 carbon atoms, a substituted or unsubstituted alkylsilyl group having 3 to 20 carbon atoms, a substituted or unsubstituted arylsilyl group having 6 to 20 carbon atoms, substituted or unsubstituted amino, acyl, carbonyl, carboxylic acid group, ester group, cyano, isocyano, mercapto, sulfinyl, sulfonyl, phosphino, and combinations thereof, having from 0 to 20 carbon atoms;
Rzeach occurrence, the same or different, is selected from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl having 3 to 20 ring carbon atoms, substituted or unsubstituted heteroalkyl having 1 to 20 carbon atoms, substituted or unsubstituted aralkyl having 7 to 30 carbon atoms, substituted or unsubstituted alkoxy having 1 to 20 carbon atoms, substituted or unsubstituted aryloxy having 6 to 30 carbon atoms, substituted or unsubstituted alkenyl having 2 to 20 carbon atoms, substituted or unsubstituted aryl having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl having 3 to 30 carbon atomsSubstituted alkylsilyl groups having 3 to 20 carbon atoms, substituted or unsubstituted arylsilane groups having 6 to 20 carbon atoms, and combinations thereof;
adjacent substituents Rx1,Rx2,Ry1,Ry2Can optionally be linked to form a ring;
substituent RzCan optionally be linked to form a ring;
represents the position of the substituent having the structure represented by formula 3 or formula 4 to which formula 1 is attached.
According to one embodiment of the invention, n is 0, 1,2, 3.
According to one embodiment of the invention, wherein n is 1.
According to one embodiment of the invention, wherein the substituent R in formula 11And R6Has a structure represented by formula 2, formula 3 or formula 4, and R1And R6Are the same or different; r2To R5,R7To R10The same or different at each occurrence is selected from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted heteroalkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted aralkyl groups having 7 to 30 carbon atoms, substituted or unsubstituted alkoxy groups having 1 to 20 carbon atoms, substituted or unsubstituted aryloxy groups having 6 to 30 carbon atoms, substituted or unsubstituted alkenyl groups having 2 to 20 carbon atoms, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl groups having 6 to 20 carbon atoms, substituted or unsubstituted amino, acyl, carbonyl, carboxylic acid group, ester group, cyano, isocyano, mercapto, sulfinyl, sulfonyl, phosphino, and combinations thereof having from 0 to 20 carbon atoms.
According to one embodiment of the invention, wherein the substituent R in formula 11And R6Has a structure represented by formula 2, formula 3 or formula 4, and R1And R6Is a phaseThe same or different; r2,R4-R5,R7And R9-R10Is hydrogen, R3And R8Identically or differently on each occurrence is selected from hydrogen, deuterium, substituted or unsubstituted alkyl having 1 to 20 carbon atoms, or substituted or unsubstituted cycloalkyl having 3 to 20 ring carbon atoms.
According to one embodiment of the invention, wherein L, identically or differently at each occurrence, is selected from a single bond, a substituted or unsubstituted arylene group having 6 to 30 carbon atoms, a substituted or unsubstituted heteroarylene group having 3 to 30 carbon atoms, or a combination thereof.
According to one embodiment of the invention, wherein L, identically or differently at each occurrence, is selected from a single bond, a substituted or unsubstituted arylene group having 6 to 12 carbon atoms, a substituted or unsubstituted heteroarylene group having 3 to 12 carbon atoms, or a combination thereof.
According to one embodiment of the invention, wherein L is selected from single bonds.
According to one embodiment of the invention, wherein Rx1And Ry1Each occurrence, the same or different, is selected from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl groups having 1 to 6 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 6 ring carbon atoms, substituted or unsubstituted heteroalkyl groups having 1 to 6 carbon atoms, substituted or unsubstituted aryl groups having 6 to 12 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 12 carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 6 carbon atoms, substituted or unsubstituted arylsilyl groups having 6 to 12 carbon atoms, and combinations thereof.
According to one embodiment of the invention, wherein Rx1And Ry1Each occurrence, the same or different, is selected from the group consisting of: hydrogen, deuterium, halogen, methyl, ethyl, n-propyl, isopropyl, cyclopropyl, n-butyl, isobutyl, tert-butyl, cyclopentyl, cyclohexyl, phenyl, trimethylsilyl, and combinations thereof.
According to one embodiment of the invention, wherein Rx1And Ry1Is hydrogen.
According to one embodiment of the present invention, wherein X1-X5Selected from C, CR, the same or different at each occurrencex1Or CRx2(ii) a And X1-X5At least one of them is selected from CRx2;Y1-Y5Selected from CR, identically or differently at each occurrencey1Or CRy2(ii) a And Y is1-Y5At least one of them is selected from CRy2
According to one embodiment of the present invention, wherein X1-X5At least one is CRx2And R isx2Each occurrence, the same or different, is selected from substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, or combinations thereof.
According to one embodiment of the present invention, wherein X1-X5At least one is CRx2And R isx2Each occurrence, identically or differently, is selected from a substituted or unsubstituted aryl group having 6 to 18 carbon atoms, a substituted or unsubstituted heteroaryl group having 3 to 18 carbon atoms, or a combination thereof.
According to one embodiment of the present invention, wherein X1-X5At least one is CRx2And R isx2Each occurrence, identically or differently, is selected from a substituted or unsubstituted aryl group having 6 to 12 carbon atoms, a substituted or unsubstituted heteroaryl group having 3 to 12 carbon atoms, or a combination thereof.
According to one embodiment of the present invention, wherein X1-X5At least one of which, except for the ring-forming atoms, is CRx2And R isx2Each occurrence, the same or different, is selected from the group consisting of: phenyl, biphenyl, terphenyl, quaterphenyl, triphenylene, tetraphenylene, 2-naphthyl, phenanthryl, anthracenyl, indenyl, fluorenyl, indolyl, carbazolyl, benzofuranyl, dibenzofuranyl, benzothiollolyl, dibenzothiapyrrolyl, benzothiophenyl, dibenzothiophenyl, dibenzoselenophenyl, and combinations thereof.
According to one embodiment of the present invention, wherein Y2To Y4At least one of which is CRy2And R isy2Each occurrence, identically or differently, is selected from substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms.
According to one embodiment of the present invention, wherein Y2To Y4At least one of which is CRy2And R isy2Each occurrence, identically or differently, is selected from substituted or unsubstituted aryl groups having 6 to 18 carbon atoms, and substituted or unsubstituted heteroaryl groups having 3 to 18 carbon atoms.
According to one embodiment of the present invention, wherein Y2To Y4At least one of which is CRy2And R isy2Each occurrence, identically or differently, is selected from substituted or unsubstituted aryl groups having 6 to 18 carbon atoms, and substituted or unsubstituted heteroaryl groups having 3 to 18 carbon atoms.
According to one embodiment of the present invention, wherein Y2To Y4At least one of which is CRy2And R isy2Each occurrence, the same or different, is selected from the group consisting of: phenyl, biphenyl, terphenyl, quaterphenyl, triphenylene, tetraphenylene, 2-naphthyl, phenanthryl, anthracenyl, indenyl, fluorenyl, indolyl, carbazolyl, benzofuranyl, dibenzofuranyl, benzothiollolyl, dibenzothiapyrrolyl, benzothiophenyl, dibenzothiophenyl, dibenzoselenophenyl, and combinations thereof.
According to one embodiment of the present invention, wherein Y1And/or Y5Is CRy2And R isy2Each occurrence, identically or differently, is selected from a substituted or unsubstituted alkyl group having 1 to 20 carbon atoms, a substituted or unsubstituted cycloalkyl group having 3 to 20 ring carbon atoms, or a combination thereof.
According to one embodiment of the present invention, wherein Y1And/or Y5Is CRy2And R isy2Each occurrence, the same or different, is selected from the group consisting of: methyl, deuterated methyl, ethyl, deuterated ethyl, n-propyl, deuterated n-propyl, isopropyl, deuterated isopropyl, cyclopropyl, deuterated cyclopropyl, n-butyl, deuterated n-butyl, isobutyl, deuterated n-butylIsobutyl, tert-butyl, deuterated tert-butyl, cyclopentyl, deuterated cyclopentyl, cyclohexyl and deuterated cyclohexyl.
According to one embodiment of the invention, wherein Z is C (R)z)2And R iszEach occurrence, the same or different, is selected from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 20 carbon atoms, and combinations thereof.
According to one embodiment of the invention, wherein Z is CRzAnd R iszEach occurrence, the same or different, is selected from the group consisting of: hydrogen, halogen, deuterium, methyl, ethyl, n-propyl, isopropyl, cyclopropyl, n-butyl, isobutyl, tert-butyl, cyclopentyl, cyclohexyl, and combinations thereof.
According to one embodiment of the present invention, wherein the compound is selected from the group consisting of compound BD1 through compound BD810, the specific structures of compound BD1 through compound BD810 are shown in claim 12.
According to an embodiment of the present invention, there is also disclosed an electroluminescent device, including:
an anode, a cathode, a anode and a cathode,
a cathode electrode, which is provided with a cathode,
and an organic layer disposed between the anode and the cathode, the organic layer comprising a compound having the structure of formula 1:
Figure BDA0002495324990000131
wherein, in the formula 1,
substituent R1-R10Wherein at least one substituent has a structure represented by formula 2;
Figure BDA0002495324990000132
and the substituent R1-R10The remaining of (a) are, identically or differently on each occurrence, selected from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted heteroalkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted aralkyl groups having 7 to 30 carbon atoms, substituted or unsubstituted alkoxy groups having 1 to 20 carbon atoms, substituted or unsubstituted aryloxy groups having 6 to 30 carbon atoms, substituted or unsubstituted alkenyl groups having 2 to 20 carbon atoms, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl groups having 6 to 20 carbon atoms, substituted or unsubstituted amino, acyl, carbonyl, carboxylic acid group, ester group, cyano, isocyano, mercapto, sulfinyl, sulfonyl, phosphino, and combinations thereof, having from 0 to 20 carbon atoms;
wherein, in the formula 2,
l is selected, identically or differently on each occurrence, from a single bond, a substituted or unsubstituted arylene group having 6 to 60 carbon atoms, a substituted or unsubstituted heteroarylene group having 3 to 60 carbon atoms, or a combination thereof;
X1-X5selected, identically or differently at each occurrence, from C, CRx1,CRx2Or N; and X1-X5At least two of them are adjacent to each other and are connected with the group of formula 2, X1-X5At least one of which is CRx2
Y1-Y5Selected from CR, identically or differently at each occurrencey1,CRy2Or N; and Y is1-Y5At least one of which is CRy2
Z is selected, identically or differently on each occurrence, from C (R)z)2,NRzO, S or Se;
Rx1and Ry1Each occurrence is the same or different and is selected fromA group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted heteroalkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted aralkyl groups having 7 to 30 carbon atoms, substituted or unsubstituted alkoxy groups having 1 to 20 carbon atoms, substituted or unsubstituted aryloxy groups having 6 to 30 carbon atoms, substituted or unsubstituted alkenyl groups having 2 to 20 carbon atoms, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl groups having 6 to 20 carbon atoms, substituted or unsubstituted amino, acyl, carbonyl, carboxylic acid group, ester group, cyano, isocyano, mercapto, sulfinyl, sulfonyl, phosphino, and combinations thereof, having from 0 to 20 carbon atoms;
Rx2and Ry2Each occurrence, the same or different, is selected from the group consisting of: deuterium, halogen, a substituted or unsubstituted alkyl group having 1 to 20 carbon atoms, a substituted or unsubstituted cycloalkyl group having 3 to 20 ring carbon atoms, a substituted or unsubstituted heteroalkyl group having 1 to 20 carbon atoms, a substituted or unsubstituted aralkyl group having 7 to 30 carbon atoms, a substituted or unsubstituted alkoxy group having 1 to 20 carbon atoms, a substituted or unsubstituted aryloxy group having 6 to 30 carbon atoms, a substituted or unsubstituted alkenyl group having 2 to 20 carbon atoms, a substituted or unsubstituted aryl group having 6 to 30 carbon atoms, a substituted or unsubstituted heteroaryl group having 3 to 30 carbon atoms, a substituted or unsubstituted alkylsilyl group having 3 to 20 carbon atoms, a substituted or unsubstituted arylsilyl group having 6 to 20 carbon atoms, substituted or unsubstituted amino, acyl, carbonyl, carboxylic acid group, ester group, cyano, isocyano, mercapto, sulfinyl, sulfonyl, phosphino, and combinations thereof, having from 0 to 20 carbon atoms;
represents a position where the substituent having the structure represented by formula 2 is linked to formula 1;
n is 0, 1,2, 3,4 or 5;
Rzat each occurrenceThe same or different is selected from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted heteroalkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted aralkyl groups having 7 to 30 carbon atoms, substituted or unsubstituted alkoxy groups having 1 to 20 carbon atoms, substituted or unsubstituted aryloxy groups having 6 to 30 carbon atoms, substituted or unsubstituted alkenyl groups having 2 to 20 carbon atoms, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl groups having 6 to 20 carbon atoms, and combinations thereof;
adjacent substituents Rx1,Rx2,Ry1,Ry2Can optionally be linked to form a ring;
substituent RzCan optionally be linked to form a ring.
According to one embodiment of the present invention, wherein the organic layer comprises a light emitting layer, wherein the light emitting layer comprises a compound having a structure of formula 1.
According to one embodiment of the present invention, wherein the light emitting layer further comprises a host material.
According to one embodiment of the present invention, wherein the host material comprises a compound having the structure of formula 5:
Figure BDA0002495324990000141
wherein, in the formula 5,
Rg1to Rg8Each independently selected from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl having 3 to 20 ring carbon atoms, substituted or unsubstituted heteroalkyl having 1 to 20 carbon atoms, substituted or unsubstituted aralkyl having 7 to 30 carbon atoms, substituted or unsubstituted alkoxy having 1 to 20 carbon atoms, or a pharmaceutically acceptable salt thereofSubstituted or unsubstituted aryloxy groups having 6 to 30 carbon atoms, substituted or unsubstituted alkenyl groups having 2 to 20 carbon atoms, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl groups having 6 to 20 carbon atoms, substituted or unsubstituted amino groups having 0 to 20 carbon atoms, acyl groups, carbonyl groups, carboxylic acid groups, ester groups, cyano groups, isocyano groups, mercapto groups, sulfinyl groups, sulfonyl groups, phosphino groups, and combinations thereof;
Rg9and Rg10Each independently selected from substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, or substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms.
According to one embodiment of the invention, a compound formula is also disclosed, which comprises a compound with a structure shown in formula 1, wherein the specific structure of the compound is shown in any embodiment.
In combination with other materials
The materials described herein for use in particular layers in an organic light emitting device may be used in combination with various other materials present in the device. Combinations of these materials are described in detail in U.S. patent application Ser. No. 0132-0161 of U.S. 2016/0359122A1, the entire contents of which are incorporated herein by reference. The materials described or referenced therein are non-limiting examples of materials that may be used in combination with the compounds disclosed herein, and one skilled in the art can readily review the literature to identify other materials that may be used in combination.
Materials described herein as being useful for particular layers in an organic light emitting device can be used in combination with a variety of other materials present in the device. For example, the light emitting dopants disclosed herein may be used in conjunction with a variety of hosts, transport layers, barrier layers, injection layers, electrodes, and other layers that may be present. Combinations of these materials are described in detail in U.S. patent application Ser. No. US2015/0349273A1, paragraph 0080-0101, the entire contents of which are incorporated herein by reference. The materials described or referenced therein are non-limiting examples of materials that may be used in combination with the compounds disclosed herein, and one skilled in the art can readily review the literature to identify other materials that may be used in combination.
In the examples of material synthesis, all reactions were carried out under nitrogen unless otherwise stated. All reaction solvents were anhydrous and used as received from commercial sources. The synthesis product is subjected to structural validation and characterization using one or more equipment conventional in the art (including, but not limited to, Bruker's nuclear magnetic resonance apparatus, Shimadzu's liquid chromatograph-mass spectrometer, gas chromatograph-mass spectrometer, differential scanning calorimeter, Shanghai prism-based fluorescence spectrophotometer, Wuhan Corset's electrochemical workstation, Anhui Beidek's sublimator, etc.) in a manner well known to those skilled in the art. In an embodiment of the device, the device characteristics are also tested using equipment conventional in the art (including, but not limited to, an evaporator manufactured by Angstrom Engineering, an optical test system manufactured by Fushida, Suzhou, an ellipsometer manufactured by Beijing Mass., etc.) in a manner well known to those skilled in the art. Since the relevant contents of the above-mentioned device usage, testing method, etc. are known to those skilled in the art, the inherent data of the sample can be obtained with certainty and without being affected, and therefore, the relevant contents are not described in detail in this patent.
Materials synthesis example:
the preparation method of the compound of the present invention is not limited, and the following compounds are typically but not limited to, and the synthetic route and the preparation method thereof are as follows:
synthesis example 1: synthesis of Compound BD176
First step of
Figure BDA0002495324990000151
2-bromo-4-iodo-1-methylbenzene (100g,337mmol), phenylboronic acid (49g,404mmol), Pd (PPh)3)4(7.8g,6.8mmol),K2CO3(116g,843mmol) was placed in a 1000mL three-necked flask, and 340mL of toluene, THF110mL,H2O110mL substitution of N2. Heating to 78 ℃ for reaction. The reaction is carried out until the raw materials completely react, and column chromatography purification is carried out to obtain the intermediate 1(80g,325mmol, 97% yield) of colorless oily liquid.
Second step of
Figure BDA0002495324990000161
Intermediate 1(81g, 329mmol), NBS (61g,345mmol) was placed in a 2L two-necked flask and 1.3L acetonitrile was added to replace N2Heating to 80 deg.C, and stirring for reaction. Benzoyl peroxide (BPO, 8g, 33mmol) was added portionwise. The reaction was completed until the starting material reacted completely, and purified by column chromatography to give intermediate 2(82g,253mmol, 77% yield) as a white solid.
The third step
Figure BDA0002495324990000162
LDA (130mL,260mmol) was placed in a 500mL three-necked flask, stirred under dry ice-ethanol for half an hour, methyl isobutyrate (30mL,260mmol) was added, and stirring was continued for half an hour. Intermediate 2(80g,130mmol) was added. The reaction is carried out until the raw material reaction is completed, and column chromatography purification is carried out to obtain the intermediate 3(50g,145mmol, 98% yield) which is light yellow oily matter.
The fourth step
Figure BDA0002495324990000163
Intermediate 3(78g,227mmol), KOH (88g,1.57mol) were mixed and H was added2O230 mL and methanol 23mL, and heating to 100 ℃ for reaction until TLC detection reaction is finished. After cooling and returning the reaction to room temperature, concentrated HCl was added to adjust the pH of the system to acidity, and the intermediate (71g,227mmol) was obtained by filtration.
The intermediate (20g, 60mmol) was dissolved in 200mL of dichloromethane, and N was passed through the solution2Adding one drop of DMF, gradually adding oxalyl chloride (30mL, 60mmol) dropwise until no gas is generated in the systemAfter soaking, the reaction was transferred to an ice-water bath and stirred for half an hour, aluminum trichloride (8g, 60mmol) was added in portions and monitored by TLC until the reaction was complete. Filtered through celite and concentrated. Column chromatography (PE as eluent) gave intermediate 4 as a white solid (6g,18.8mmol, 31% yield).
The fifth step
Figure BDA0002495324990000164
Intermediate 4(18g,57mmol) was dissolved in 180mL of methanol, stirred in an ice-water bath for half an hour and NaBH was added portionwise4After completion of the reaction, the reaction mixture was filtered through celite, and the filtrate was concentrated.
The product was dissolved in dichloromethane and Et was added3SiH (12.7g,111mmol), was stirred in an ice-water bath for half an hour, gradually added TFA (18g, 155mmol) dropwise until the starting material reacted completely, and purified by column chromatography to give intermediate 5(12g, 39.9mmol, 70% yield) as a colorless oil.
The sixth step
Figure BDA0002495324990000171
Pd is added at room temperature under the protection of nitrogen2(dba)3(910mg,0.99mmol), BINAP (1.18g,1.99mmol), intermediate 5(6g,19.9mmol), 4-methyl- [1, 1' -biphenyl]-3-amine (5.5g, 30mmol) and t-BuONa (3.8g,39.8mmol) were added to toluene (100mL) and the system was heated to 120 ℃ for 2 h. After the reaction was completed, purification was performed by column chromatography to obtain intermediate 6(6.7g,16.4mmol, yield 82.7%) as a white solid.
Seventh step
Figure BDA0002495324990000172
Under the protection of nitrogen at room temperature, 1, 6-dibromopyrene (2.38g,6.6mmol), intermediate 6(6.2g, 15.2mmol), Pd (OAc)2(74mg,0.33mmol),t-Bu3P·HBF4(191mg,0.66mmol) and t-BuONa (1.46g,15.2mmol), xylene (33mL) was added and the system was heated to 95 ℃. After the reaction was completed, the product compound BD176(6g, 5.97mmol, 90% yield) was obtained through column chromatography purification. The product was identified as the target product with a molecular weight of 1004.5.
Synthesis example 2: synthesis of Compound BD109
The first step is as follows:
Figure BDA0002495324990000173
pd is added at room temperature under the protection of nitrogen2(dba)3(910mg,0.99mmol), BINAP (1.18g,1.99mmol), intermediate 5(6g,19.9mmol), [1, 1' -biphenylyl]-3-amine (5.5g, 30mmol) and t-BuONa (3.8g,39.8mmol) were added to toluene (100mL) and the system was heated to 120 ℃ for 2 h. After the reaction was completed, purification was performed by column chromatography to obtain intermediate 7(6.7g, 16.4mmol, 83% yield) as a colorless oil.
The second step is that:
Figure BDA0002495324990000181
under the protection of nitrogen at room temperature, 1, 6-dibromopyrene (2.2g, 6.1mmol), intermediate 7(5.5g, 14mmol), Pd (OAc)2(68mg,0.3mmol),tBu3PH+BF4 -(174mg, 0.6mmol) and t-BuONa (1.3g, 14mmol), xylene (30mL) was added and the system was heated to 95 ℃. After the reaction was completed, purification was performed by column chromatography to obtain BD109(5g, 5.1mmol, yield 84%) as a yellow-green solid. The product was identified as the target product with a molecular weight of 976.5.
Synthesis comparative example 1: synthesis of comparative Compound A
The first step is as follows:
Figure BDA0002495324990000182
pd (OAc)2(52mg,0.23mmol),tBu3PH+BF4 -(134mg, 0.46mmol) was charged into a 250mL two-necked flask and xylene (100mL) was added. Introducing N into the solution2After 20 minutes until the color did not change any more, 1, 6-dibromopyrene (2.77g, 7.68mmol) and the compound bis (4-methyl- [1, 1' -biphenyl) were added successively]-3-yl) amine (5.9g, 16.9mmol), sodium tert-butoxide (3.69g, 38.4 mmol). Continuously introducing N2For 10 minutes, the system was heated to 90 ℃ until the reaction of the starting materials was complete. After the reaction was completed, purification was performed by column chromatography to obtain the product, comparative compound A (2.4g, 2.68mmol, yield 34.9%). The product was identified as the target product with a molecular weight of 896.4.
Synthesis comparative example 2: synthesis of comparative Compound B
The first step is as follows:
Figure BDA0002495324990000184
LDA (100mL, 200mmol) was placed in a 250mL three-necked flask, stirred under dry ice-ethanol for half an hour, methyl isobutyrate (23mL, 200mmol) was added, and stirring was continued for half an hour. Benzyl bromide (25g, 100mmol) was added and filtered through celite. After concentration, a crude product intermediate 8 is obtained and directly subjected to the next reaction.
The second step is that:
Figure BDA0002495324990000183
intermediate 8(27g, 100mmol) and potassium hydroxide (56g,1mol) were mixed, 100mL of water and 10mL of methanol were added, and the mixture was heated to 100 ℃ for reaction until the TLC detection reaction was complete. Cooling, adding concentrated hydrochloric acid to adjust system pH to acidity after reaction returns to room temperature, extracting organic phase with ethyl acetate, combining organic phases, and concentrating.
Dissolve the above product (27g, 100mmol) in 200mL of dichloromethane, N2Blowing gas, adding one drop of DMF, gradually adding oxalyl chloride (12.8mL, 120mmol) dropwise, after the system does not generate bubbles any more, moving the reaction to an ice water bath, stirring for half an hour, and batchingAluminum trichloride (14.3g,108mmol) was added and monitored by TLC until the reaction was complete. Chromatography by column eluting with PE gave intermediate 9(22g, 91.6mmol, 85% yield) as a white solid.
The third step:
Figure BDA0002495324990000191
intermediate 9(22g, 99mmol) was dissolved in 300mL of methanol, stirred in an ice-water bath for half an hour and NaBH was added in portions4After completion of the reaction, the reaction mixture was filtered through celite, and the filtrate was concentrated.
The product was dissolved in dichloromethane and Et was added3SiH (22.5g, 198mmol), stirred in an ice-water bath for half an hour, gradually added TFA (34g, 297mmol) dropwise, concentrated, and purified by column chromatography to give intermediate 10(7.7g, 34.4mmol, 35% yield) as a colorless oil.
The fourth step:
Figure BDA0002495324990000192
pd is added at room temperature under the protection of nitrogen2(dba3) (1g, 1.1mmol), intermediate 10(5.1g, 22.7mmol), 4-methyl- [1, 1' -biphenyl]-3-amine (5g, 27.2mmol), BINAP (1.4g, 2.2mmol) and t-BuONa (4.7g, 49.6mmol) were added to xylene (100mL) and the system was heated to 90 ℃ for reaction overnight. Purification by column chromatography after the reaction was complete gave intermediate 11 as a white solid (5.7g, 17.4mmol, 76% yield).
The fifth step:
Figure BDA0002495324990000193
under the protection of nitrogen at room temperature, 1, 6-dibromopyrene (2.6g, 7.2mmol) and 2, 2-dimethyl-N- (4-methyl- [1, 1' -biphenyl) are added]-3-yl) -2, 3-dihydro-1H-indan-4-amine (5.7g, 17.4mmol), Pd (OAc)2(161mg,0.72mmol),t-Bu3P·BF4(406mg,1.4mmol) and t-BuONa (2.7g, 28.2mmol) were added to xylene (20mL) and the system was heated to 100 ℃ until the reaction was complete. And purified by column chromatography to give comparative compound B as a yellow-green solid (1.2g, 1.41mmol, 20% yield). The product was identified as the target product with a molecular weight of 852.4.
Synthesis comparative example 3: synthesis of comparative Compound C
The first step is as follows:
Figure BDA0002495324990000201
pd is added at room temperature under the protection of nitrogen2(dba)3(910mg,0.99mmol), BINAP (1.18g,1.99mmol), intermediate 5(6g,19.9mmol), aniline (2.79g,30mmol) and t-BuONa (3.8g,39.8mmol), toluene (100mL) was added and the system was heated to 120 ℃ for 3 h. After the reaction was completed, purification was performed by column chromatography to obtain intermediate 12(5.3g,16.9mmol, yield 85%) as a colorless oily substance.
The second step is that:
Figure BDA0002495324990000202
under the protection of nitrogen at room temperature, 1, 6-dibromopyrene (2.38g,6.6mmol), intermediate 12(4.76g,15.2mmol), Pd (OAc)2(74mg,0.33mmol),t-Bu3P·HBF4(191mg,0.66mmol) and t-BuONa (1.46g,15.2mmol) were added to xylene (30mL) and the system was heated to 95 ℃. After the reaction was completed, it was purified by column chromatography to obtain comparative compound C (4.68g,5.67mmol, yield 86%) as a yellow-green solid. The product was identified as the target product with a molecular weight of 824.4.
It will be appreciated by those skilled in the art that the above preparation method is only an illustrative example, and that those skilled in the art can modify it to obtain other structures of the compounds of the present invention.
Device example 1
First, a glass substrate having an Indium Tin Oxide (ITO) anode of 80nm thickness was cleaned, and then oxygen plasma was usedAnd UV ozone treatment. After treatment, the substrate was dried in a glove box to remove moisture. The substrate is then mounted on a substrate holder and loaded into a vacuum chamber. The organic layer specified below was in a vacuum of about 10 degrees-8In the case of torr, the evaporation was performed by thermal vacuum evaporation at a rate of 0.2 to 2 angstroms/second in turn on an ITO anode. Compound HI was used as Hole Injection Layer (HIL). The compound HT is used as a Hole Transport Layer (HTL). Compound EB was used as an Electron Blocking Layer (EBL). Then compound BD176 is doped in compound BH and co-evaporated to serve as the light emitting layer (EML). Compound HB was used as a Hole Blocking Layer (HBL). On the hole blocking layer, compound ET and 8-hydroxyquinoline-lithium (Liq) were co-evaporated as an Electron Transport Layer (ETL). Finally, 8-hydroxyquinoline-lithium (Liq) was evaporated to a thickness of 1nm as an electron injection layer, and 120nm of aluminum as a cathode. The device was then transferred back to the glove box and encapsulated with a glass lid and moisture absorber to complete the device.
Device example 2
The embodiment of device example 2 is the same as device example 1 except that compound BD109 is used instead of compound BD176 in the light emitting layer (EML).
Device comparative example 1
Device comparative example 1 was the same as device example 1 except that compound a was used in place of compound BD176 in the light emitting layer (EML).
Device comparative example 2
Device comparative example 2 was the same as device example 1 except that compound C was used in place of compound BD176 in the light emitting layer (EML).
Device comparative example 3
Device comparative example 3 was the same as device example 1 except that compound B was used in place of compound BD176 in the light emitting layer (EML).
The detailed structure and thickness of the device layer portions are shown in table 1. Wherein more than one layer of the materials used is obtained by doping different compounds in the stated weight ratios.
TABLE 1 device structures of device examples and comparative examples
Figure BDA0002495324990000211
The material structure used in the device is as follows:
Figure BDA0002495324990000212
Figure BDA0002495324990000221
IVL was measured for all the examples and comparative devices at different current densities and voltages. At a constant current of 1000cd/m2External Quantum Efficiency (EQE), maximum emission wavelength (. lamda.) was measuredmax) Full width at half maximum (FWHM) and CIE data.
Table 2 device data for example 1, comparative example 1 and comparative example 3
Device numbering CIE(x,y) λmax(nm) FWHM(nm) EQE(%)
Example 1 0.135,0.118 461 29.70 9.12
Comparative example 1 0.140,0.098 456 32.20 8.88
Comparative example 3 0.135,0.118 461 30.10 9.05
Discussion:
table 2 shows the device data of example 1, comparative example 1 and comparative example 3, from which it can be seen that the device example 1 has an External Quantum Efficiency (EQE) of 9.12%, a maximum emission wavelength of 461nm, a CIE of (0.135,0.118) and a half-peak width of 29.7 nm; comparative example 1 the External Quantum Efficiency (EQE) was 8.88%, the maximum emission wavelength was 456nm, the CIE was (0.140,0.098), and the half-peak width was 32.2 nm. Example 1 showed an increase in EQE of 2.7% and a narrowing of the half-width by 3.5nm compared to comparative example 1. From the results of example 1 compared with comparative example 1, due to the introduction of a specific benzo-saturated ring substituent into one aryl group in the arylamine, higher EQE and narrower half-peak width are obtained in the device results, and the blue luminescence performance is effectively increased.
Comparative example 3 the External Quantum Efficiency (EQE) was 9.05%, the maximum emission wavelength was 461nm, the CIE was (0.135,0.118), and the half-peak width was 30.1 nm. Compared with the result of comparative example 3, the EQE is improved by 0.77 percent due to the further introduction of the aryl group on the benzo saturated ring, and the half-peak width is narrowed by 0.4nm, so that the blue luminescence property is effectively improved.
Table 3 device data for example 2 and comparative example 2
Figure BDA0002495324990000222
Figure BDA0002495324990000231
Discussion:
table 3 shows the device data of example 2 and comparative example 2, from which it can be seen that example 2 has an External Quantum Efficiency (EQE) of 9.02%, a maximum emission wavelength of 463nm, a CIE of (0.133,0.129), and a half-peak width of 30.5 nm; comparative example 2 the External Quantum Efficiency (EQE) was 8.65%, the maximum emission wavelength was 463nm, CIE was (0.133 ), and the half-peak width was 30.5 nm. Compared with comparative example 2, the EQE of example 2 is improved by 4.27%, and the half-peak width and the maximum emission wavelength are kept unchanged. Example 2 it can be seen that an increase in EQE can be achieved by introducing a phenyl substituent in the other aryl group of the arylamine compared to comparative example 2.
In conclusion, the novel compound obtained by introducing the substituted hexabasic (hetero) aromatic ring and the saturated ring structure into one aryl group of the aromatic amine substituted pyrene compound and introducing the substituted (hetero) aryl group into the other aryl group is applied to the organic electroluminescent device, so that the blue emission wavelength, the EQE and the half-peak width are higher, and the comprehensive performance of the device is improved.
It should be understood that the various embodiments described herein are illustrative only and are not intended to limit the scope of the invention. Thus, the invention as claimed may include variations from the specific embodiments and preferred embodiments described herein, as will be apparent to those skilled in the art. Many of the materials and structures described herein may be substituted with other materials and structures without departing from the spirit of the present invention. It should be understood that various theories as to why the invention works are not intended to be limiting.

Claims (16)

1. A compound having the structure of formula 1:
Figure FDA0002495324980000011
wherein, in the formula 1,
substituent R1-R10At least one of which has the structure of formula 2:
Figure FDA0002495324980000012
and the substituent R1-R10The remaining of (a) are, identically or differently on each occurrence, selected from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted heteroalkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted aralkyl groups having 7 to 30 carbon atoms, substituted or unsubstituted alkoxy groups having 1 to 20 carbon atoms, substituted or unsubstituted aryloxy groups having 6 to 30 carbon atoms, substituted or unsubstituted alkenyl groups having 2 to 20 carbon atoms, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl groups having 6 to 20 carbon atoms, substituted or unsubstituted amino, acyl, carbonyl, carboxylic acid group, ester group, cyano, isocyano, mercapto, sulfinyl, sulfonyl, phosphino, and combinations thereof, having from 0 to 20 carbon atoms;
wherein, in the formula 2,
l is selected, identically or differently on each occurrence, from a single bond, a substituted or unsubstituted arylene group having 6 to 60 carbon atoms, a substituted or unsubstituted heteroarylene group having 3 to 60 carbon atoms, or a combination thereof;
X1-X5selected, identically or differently at each occurrence, from C, CRx1,CRx2Or N; and X1-X5At least two of them are adjacent to each other and are connected with the group of formula 2, X1-X5At least one of which is CRx2
Y1-Y5Selected from CR, identically or differently at each occurrencey1,CRy2Or N; and Y is1-Y5At least one of which is CRy2
Z is selected, identically or differently on each occurrence, from C (R)z)2,NRzO, S or Se;
Rx1and Ry1Each occurrence, the same or different, is selected from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted heteroalkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted aralkyl groups having 7 to 30 carbon atoms, substituted or unsubstituted alkoxy groups having 1 to 20 carbon atoms, substituted or unsubstituted aryloxy groups having 6 to 30 carbon atoms, substituted or unsubstituted alkenyl groups having 2 to 20 carbon atoms, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl groups having 6 to 20 carbon atoms, substituted or unsubstituted amino, acyl, carbonyl, carboxylic acid group, ester group, cyano, isocyano, mercapto, sulfinyl, sulfonyl, phosphino, and combinations thereof, having from 0 to 20 carbon atoms;
Rx2and Ry2Each occurrence, the same or different, is selected from the group consisting of: deuterium, halogen, a substituted or unsubstituted alkyl group having 1 to 20 carbon atoms, a substituted or unsubstituted cycloalkyl group having 3 to 20 ring carbon atoms, a substituted or unsubstituted heteroalkyl group having 1 to 20 carbon atoms, a substituted or unsubstituted aralkyl group having 7 to 30 carbon atoms, a substituted or unsubstituted alkoxy group having 1 to 20 carbon atoms, a substituted or unsubstituted aryloxy group having 6 to 30 carbon atoms, a substituted or unsubstituted alkenyl group having 2 to 20 carbon atoms, a substituted or unsubstituted aryl group having 6 to 30 carbon atoms, a substituted or unsubstituted heteroaryl group having 3 to 30 carbon atoms, a substituted or unsubstituted alkylsilyl group having 3 to 20 carbon atoms, a substituted or unsubstituted arylsilyl group having 6 to 20 carbon atoms, substituted or unsubstituted amino, acyl, carbonyl, carboxylic acid having 0 to 20 carbon atomsA group, an ester group, a cyano group, an isocyano group, a mercapto group, a sulfinyl group, a sulfonyl group, a phosphino group, and combinations thereof;
represents the position of the substituent with the structure of formula 2 connected with formula 1;
n is 0, 1,2, 3,4 or 5;
Rzeach occurrence, the same or different, is selected from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted heteroalkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted aralkyl groups having 7 to 30 carbon atoms, substituted or unsubstituted alkoxy groups having 1 to 20 carbon atoms, substituted or unsubstituted aryloxy groups having 6 to 30 carbon atoms, substituted or unsubstituted alkenyl groups having 2 to 20 carbon atoms, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl groups having 6 to 20 carbon atoms, and combinations thereof;
adjacent substituents Rx1,Rx2,Ry1,Ry2Can optionally be linked to form a ring;
substituent RzCan optionally be linked to form a ring.
2. The compound of claim 1, wherein the substituent having formula 2 further has the structure of formula 3 or formula 4:
Figure FDA0002495324980000021
wherein, in formula 3 and formula 4,
X1-X3and X5Selected from CR, identically or differently at each occurrencex1,CRx2Or N; and X1-X3And X5At least one of which is CRx2
Y1-Y5、L、Z、n、Rx1And Rx2Has the same definition as in claim 1;
represents a position where the substituent having a structure represented by formula 3 or formula 4 is attached to formula 1.
3. The compound of any one of claims 1-2, wherein n is 0, 1,2, 3; preferably, n is 1.
4. The compound of claim 2, wherein substituent R1And R6Has a structure represented by formula 3 or formula 4, and R1And R6Are the same or different; r2To R5,R7To R10The same or different at each occurrence is selected from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted heteroalkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted aralkyl groups having 7 to 30 carbon atoms, substituted or unsubstituted alkoxy groups having 1 to 20 carbon atoms, substituted or unsubstituted aryloxy groups having 6 to 30 carbon atoms, substituted or unsubstituted alkenyl groups having 2 to 20 carbon atoms, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl groups having 6 to 20 carbon atoms, substituted or unsubstituted amino, acyl, carbonyl, carboxylic acid group, ester group, cyano, isocyano, mercapto, sulfinyl, sulfonyl, phosphino, and combinations thereof, having from 0 to 20 carbon atoms;
preferably, the substituent R1And R6Has a structure represented by formula 2, formula 3 or formula 4, and R1And R6Are the same or different; r2,R4-R5,R7And R9-R10Is hydrogen, R3And R8Is selected, identically or differently on each occurrence, from hydrogen, deuterium, substituted or unsubstituted alkyl having 1 to 20 carbon atoms, or substituted or unsubstituted alkyl havingCycloalkyl groups having 3 to 20 ring carbon atoms.
5. The compound of any one of claims 1-4, wherein L, identically or differently at each occurrence, is selected from a single bond, a substituted or unsubstituted arylene having 6 to 30 carbon atoms, a substituted or unsubstituted heteroarylene having 3 to 30 carbon atoms, or a combination thereof;
preferably, L is selected, identically or differently on each occurrence, from a single bond, a substituted or unsubstituted arylene group having 6 to 12 carbon atoms, a substituted or unsubstituted heteroarylene group having 3 to 12 carbon atoms, or a combination thereof;
more preferably, L is selected from single bonds.
6. The compound of any one of claims 2-5, wherein X1-X3And X5Selected from CR, identically or differently at each occurrencex1Or CRx2And X1-X3And X5At least one of them is selected from CRx2;Y1-Y5Selected from CR, identically or differently at each occurrencey1Or CRy2And Y is1-Y5At least one of them is selected from CRy2
7. The compound of any one of claims 1-6, wherein Rx1And Ry1Each occurrence, the same or different, is selected from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl groups having 1 to 6 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 6 ring carbon atoms, substituted or unsubstituted heteroalkyl groups having 1 to 6 carbon atoms, substituted or unsubstituted aryl groups having 6 to 12 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 12 carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 6 carbon atoms, substituted or unsubstituted arylsilyl groups having 6 to 12 carbon atoms, and combinations thereof;
preferably, wherein Rx1And Ry1Each occurrence, the same or different, is selected from the group consisting of: hydrogen, deuterium, halogen, methyl, ethyl, n-propylIsopropyl, cyclopropyl, n-butyl, isobutyl, t-butyl, cyclopentyl, cyclohexyl, phenyl, trimethylsilyl, and combinations thereof.
More preferably, Rx1And Ry1Is hydrogen.
8. The compound of any one of claims 1-7, wherein X1-X5At least one is CRx2And R isx2Each occurrence, identically or differently, is selected from a substituted or unsubstituted aryl group having 6 to 30 carbon atoms, a substituted or unsubstituted heteroaryl group having 3 to 30 carbon atoms, or a combination thereof;
preferably, Rx2Each occurrence, the same or different, is selected from the group consisting of: phenyl, biphenyl, terphenyl, quaterphenyl, triphenylene, tetraphenylene, 2-naphthyl, phenanthryl, anthracenyl, indenyl, fluorenyl, indolyl, carbazolyl, benzofuranyl, dibenzofuranyl, benzothiollolyl, dibenzothiapyrrolyl, benzothiophenyl, dibenzothiophenyl, dibenzoselenophenyl, and combinations thereof.
9. The compound of any one of claims 1-8, wherein Y is2-Y4At least one is CRy2And R isy2Selected from substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, or combinations thereof;
preferably, Ry2Each occurrence, the same or different, is selected from the group consisting of: phenyl, biphenyl, terphenyl, quaterphenyl, triphenylene, tetraphenylene, 2-naphthyl, phenanthryl, anthracenyl, indenyl, fluorenyl, indolyl, carbazolyl, benzofuranyl, dibenzofuranyl, benzothiollolyl, dibenzothiapyrrolyl, benzothiophenyl, dibenzothiophenyl, dibenzoselenophenyl, and combinations thereof.
10. The compound of claim 9, wherein Y1And/or Y5Is CRy2And R isy2Identical or different at each occurrenceSelected from substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, or combinations thereof;
preferably, Ry2Each occurrence, the same or different, is selected from the group consisting of: methyl, deuterated methyl, ethyl, deuterated ethyl, n-propyl, deuterated n-propyl, isopropyl, deuterated isopropyl, cyclopropyl, deuterated cyclopropyl, n-butyl, deuterated n-butyl, isobutyl, deuterated isobutyl, tert-butyl, deuterated tert-butyl, cyclopentyl, deuterated cyclopentyl, cyclohexyl, and deuterated cyclohexyl.
11. The compound of any one of claims 1-10, wherein Z is C (R)z)2And R iszEach occurrence, the same or different, is selected from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 20 carbon atoms, and combinations thereof;
preferably, RzEach occurrence, the same or different, is selected from the group consisting of: hydrogen, halogen, deuterium, methyl, ethyl, n-propyl, isopropyl, cyclopropyl, n-butyl, isobutyl, tert-butyl, cyclopentyl, cyclohexyl, and combinations thereof;
substituent RzCan optionally be linked to form a ring.
12. The compound of claim 1, wherein the compound is selected from the group consisting of:
Figure FDA0002495324980000041
Figure FDA0002495324980000051
Figure FDA0002495324980000061
Figure FDA0002495324980000071
Figure FDA0002495324980000081
Figure FDA0002495324980000091
Figure FDA0002495324980000101
Figure FDA0002495324980000111
Figure FDA0002495324980000121
Figure FDA0002495324980000131
Figure FDA0002495324980000141
Figure FDA0002495324980000151
Figure FDA0002495324980000161
Figure FDA0002495324980000171
Figure FDA0002495324980000181
Figure FDA0002495324980000191
Figure FDA0002495324980000201
Figure FDA0002495324980000211
Figure FDA0002495324980000221
Figure FDA0002495324980000231
Figure FDA0002495324980000241
Figure FDA0002495324980000251
Figure FDA0002495324980000261
Figure FDA0002495324980000271
Figure FDA0002495324980000281
Figure FDA0002495324980000291
Figure FDA0002495324980000301
Figure FDA0002495324980000311
Figure FDA0002495324980000321
Figure FDA0002495324980000331
Figure FDA0002495324980000341
Figure FDA0002495324980000351
Figure FDA0002495324980000361
Figure FDA0002495324980000371
Figure FDA0002495324980000381
Figure FDA0002495324980000391
Figure FDA0002495324980000401
Figure FDA0002495324980000411
Figure FDA0002495324980000421
Figure FDA0002495324980000431
Figure FDA0002495324980000441
Figure FDA0002495324980000451
Figure FDA0002495324980000461
Figure FDA0002495324980000471
Figure FDA0002495324980000481
Figure FDA0002495324980000491
Figure FDA0002495324980000501
Figure FDA0002495324980000511
Figure FDA0002495324980000521
Figure FDA0002495324980000531
Figure FDA0002495324980000541
Figure FDA0002495324980000551
Figure FDA0002495324980000561
Figure FDA0002495324980000571
Figure FDA0002495324980000581
Figure FDA0002495324980000591
Figure FDA0002495324980000601
Figure FDA0002495324980000611
Figure FDA0002495324980000621
Figure FDA0002495324980000631
Figure FDA0002495324980000641
Figure FDA0002495324980000651
Figure FDA0002495324980000661
Figure FDA0002495324980000671
Figure FDA0002495324980000681
Figure FDA0002495324980000691
Figure FDA0002495324980000701
Figure FDA0002495324980000711
Figure FDA0002495324980000721
13. an electroluminescent device, comprising:
an anode, a cathode, a anode and a cathode,
a cathode electrode, which is provided with a cathode,
and an organic layer disposed between the anode and the cathode, the organic layer comprising a compound having the structure of formula 1:
Figure FDA0002495324980000722
wherein, in the formula 1,
substituent R1-R10At least one of them has a structure represented by formula 2;
Figure FDA0002495324980000723
and the substituent R1-R10The remaining of (a) are, identically or differently on each occurrence, selected from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted heteroalkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted aralkyl groups having 7 to 30 carbon atoms, substituted or unsubstituted alkoxy groups having 1 to 20 carbon atoms, substituted or unsubstituted aryloxy groups having 6 to 30 carbon atoms, substituted or unsubstituted alkenyl groups having 2 to 20 carbon atoms, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl groups having 6 to 20 carbon atoms, substituted or unsubstituted amino, acyl, carbonyl, carboxylic acid group, ester group, nitrile group, isonitrile group, mercapto, sulfinyl, sulfonyl, phosphino, and combinations thereof, having from 0 to 20 carbon atoms;
wherein, in the formula 2,
l is selected, identically or differently on each occurrence, from a single bond, a substituted or unsubstituted arylene group having 6 to 60 carbon atoms, a substituted or unsubstituted heteroarylene group having 3 to 60 carbon atoms, or a combination thereof;
X1-X5selected, identically or differently at each occurrence, from C, CRx1,CRx2Or N; and X1-X5At least two of which are adjacent to each other are C,and is linked to X in formula 21-X5At least one of which is CRx2
Y1-Y5Selected from CR, identically or differently at each occurrencey1,CRy2Or N; and Y is1-Y5At least one of which is CRy2
Z is selected, identically or differently on each occurrence, from C (R)z)2,NRzO, S or Se;
Rx1and Ry1Each occurrence, the same or different, is selected from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted heteroalkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted aralkyl groups having 7 to 30 carbon atoms, substituted or unsubstituted alkoxy groups having 1 to 20 carbon atoms, substituted or unsubstituted aryloxy groups having 6 to 30 carbon atoms, substituted or unsubstituted alkenyl groups having 2 to 20 carbon atoms, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl groups having 6 to 20 carbon atoms, substituted or unsubstituted amino, acyl, carbonyl, carboxylic acid group, ester group, nitrile group, isonitrile group, mercapto, sulfinyl, sulfonyl, phosphino, and combinations thereof, having from 0 to 20 carbon atoms;
Rx2and Ry2Each occurrence, the same or different, is selected from the group consisting of: deuterium, halogen, substituted or unsubstituted alkyl having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl having 3 to 20 ring carbon atoms, substituted or unsubstituted heteroalkyl having 1 to 20 carbon atoms, substituted or unsubstituted aralkyl having 7 to 30 carbon atoms, substituted or unsubstituted alkoxy having 1 to 20 carbon atoms, substituted or unsubstituted aryloxy having 6 to 30 carbon atoms, substituted or unsubstituted alkenyl having 2 to 20 carbon atoms, substituted or unsubstituted aryl having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl having 3 to 30 carbon atomsA group, a substituted or unsubstituted alkylsilyl group of 3 to 20 carbon atoms, a substituted or unsubstituted arylsilyl group of 6 to 20 carbon atoms, a substituted or unsubstituted amino group of 0 to 20 carbon atoms, an acyl group, a carbonyl group, a carboxylic acid group, an ester group, a cyano group, an isocyano group, a mercapto group, a sulfinyl group, a sulfonyl group, a phosphino group, and combinations thereof;
represents a position where the substituent having the structure represented by formula 2 is linked to formula 1;
n is 0, 1,2, 3,4 or 5;
Rzeach occurrence, the same or different, is selected from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted heteroalkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted aralkyl groups having 7 to 30 carbon atoms, substituted or unsubstituted alkoxy groups having 1 to 20 carbon atoms, substituted or unsubstituted aryloxy groups having 6 to 30 carbon atoms, substituted or unsubstituted alkenyl groups having 2 to 20 carbon atoms, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl groups having 6 to 20 carbon atoms, and combinations thereof;
adjacent substituents Rx1,Rx2,Ry1,Ry2Can optionally be linked to form a ring;
substituent RzCan optionally be linked to form a ring.
14. The organic electroluminescent device as claimed in claim 13, wherein the organic layer comprises a light emitting layer, wherein the light emitting layer comprises a compound having the structure of formula 1.
15. The organic electroluminescent device according to claim 14, wherein the light-emitting layer further comprises a host material;
preferably, the host material comprises a compound having the structure of formula 5:
Figure FDA0002495324980000731
wherein, in the formula 5,
Rg1to Rg8Each occurrence, the same or different, is selected from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted heteroalkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted aralkyl groups having 7 to 30 carbon atoms, substituted or unsubstituted alkoxy groups having 1 to 20 carbon atoms, substituted or unsubstituted aryloxy groups having 6 to 30 carbon atoms, substituted or unsubstituted alkenyl groups having 2 to 20 carbon atoms, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl groups having 6 to 20 carbon atoms, substituted or unsubstituted amino, acyl, carbonyl, carboxylic acid group, ester group, nitrile group, isonitrile group, mercapto, sulfinyl, sulfonyl, phosphino, and combinations thereof, having from 0 to 20 carbon atoms;
Rg9and Rg10Each independently selected from substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, or substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms.
16. A compound formulation comprising a compound as defined by any one of claims 1 to 12.
CN202010418571.2A 2020-05-18 2020-05-18 Aromatic amine derivative organic electroluminescent material and device thereof Pending CN113683518A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010418571.2A CN113683518A (en) 2020-05-18 2020-05-18 Aromatic amine derivative organic electroluminescent material and device thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010418571.2A CN113683518A (en) 2020-05-18 2020-05-18 Aromatic amine derivative organic electroluminescent material and device thereof

Publications (1)

Publication Number Publication Date
CN113683518A true CN113683518A (en) 2021-11-23

Family

ID=78575442

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010418571.2A Pending CN113683518A (en) 2020-05-18 2020-05-18 Aromatic amine derivative organic electroluminescent material and device thereof

Country Status (1)

Country Link
CN (1) CN113683518A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100052526A1 (en) * 2008-08-26 2010-03-04 Sfc Co., Ltd. Pyrene compounds and organic electroluminescent devices using the same
US20110042660A1 (en) * 2008-02-15 2011-02-24 Idemitsu Kosan Co., Ltd. Organic luminescent medium and organic el device
US20110156016A1 (en) * 2008-07-28 2011-06-30 Masahiro Kawamura Organic light-emitting medium and organic el element
CN107556239A (en) * 2017-10-10 2018-01-09 长春海谱润斯科技有限公司 One kind contains acridine compounds and its organic luminescent device

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110042660A1 (en) * 2008-02-15 2011-02-24 Idemitsu Kosan Co., Ltd. Organic luminescent medium and organic el device
US20110156016A1 (en) * 2008-07-28 2011-06-30 Masahiro Kawamura Organic light-emitting medium and organic el element
US20100052526A1 (en) * 2008-08-26 2010-03-04 Sfc Co., Ltd. Pyrene compounds and organic electroluminescent devices using the same
CN107556239A (en) * 2017-10-10 2018-01-09 长春海谱润斯科技有限公司 One kind contains acridine compounds and its organic luminescent device

Similar Documents

Publication Publication Date Title
CN109422770B (en) Boron-containing heterocyclic compounds for OLEDs, organic light emitting devices, and compound formulations comprising the same
CN109422666B (en) Hole injection layer and charge generation layer containing a truxene-based compound
CN111196822B (en) Compound containing silafluorenyl and fluorenyl structure and electroluminescent device containing the same
CN109651065B (en) Tetraortho-phenylene anthracene compounds
CN109694368B (en) Indolocarbazole tetraphthalene compounds
CN111675697B (en) Organic electroluminescent material and device thereof
CN112876489B (en) Organic electroluminescent material and device thereof
CN109928885B (en) Tetraortho-phenylene triarylamine compounds
CN109836435B (en) Triarylamine compounds containing thiophene
CN112778283B (en) Organic electroluminescent material and device thereof
CN111675698A (en) Organic electroluminescent material and device thereof
CN114907412A (en) Organic electroluminescent material and device thereof
CN111620853A (en) Organic electroluminescent material and device thereof
CN113527316A (en) Electroluminescent material and device
CN111333611B (en) Organic electroluminescent material and device thereof
CN113527315A (en) Electroluminescent material and device
CN111100129B (en) Organic electroluminescent material and device
CN109575085B (en) Organic luminescent material containing tetra-ortho-phenylene ligand
CN112390780B (en) Electron transport material containing nitrogen hetero-spirobifluorene
CN113527317A (en) Electroluminescent material and device
CN113278033A (en) Organic electroluminescent material and device
CN112430191A (en) Pyrene compound containing aromatic amine substitution
CN112430190A (en) Aromatic amine derivative and organic electroluminescent device comprising same
CN111039928B (en) Organic electroluminescent material containing spiroalkene structure and device
CN111675707B (en) Organic electroluminescent material and device thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination